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An examination of how sickle-cell disease contributes to cognitive impairment in children. The 
definition, classification, and pathophysiology of sickle-cell disease is discussed to support the 
cognitive impairment seen within children with sickle-cell disease. The quality of life that children with 
sickle cell experience is also discussed as it plays a role in how children with sickle cell experience the 
disease. Therapeutic measures are also examined to discuss the possible interventions that can be taken 
to aide children with sickle cell manage the disease. After careful research, it is concluded that four 
factors directly cause compromised neurological function in children with sickle-cell disease; (1) 
recurrent micro infarction of the central nervous system; (2) chronic hypoxic damage to the brain or 
diminished pulmonary function; (3) sub-acute brain damage that occurred during bouts of hypoxia 
associated with events such as aplastic crisis, acute chest syndrome, and obstructive sleep apnea; and 
(4) chronic nutritional deficiency associated with increased metabolic demands. The therapeutic 
interventions that are discussed to aid in the management of sickle-cell disease are inhibition of 
hemoglobin S polymerization and reduction of the intracellular hemoglobin concentration.
Keywords: sickle-cell disease, children, therapeutic interventions, cognitive impairment, quality of life, health 
related quality of life
Introduction
Sickle cell disease of the blood that attacks the red blood cells can is prevalent in predominately ethnic 
minorities in the United States. Children who suffer from this condition have many health-related as 
well as social and emotional complications associated with this disease. One of the most interesting and 
devastating health-related complications that can occur is cognitive impairment. Lack of adequate 
oxygen and blood supply to the brain as well as brain infracts (strokes) can contribute to the prevalence 
of cognitive impairment seen within children who have sickle cell disease. Apart from the loss of 
childhood freedoms from being brought in and out of hospital rooms, extensive tests, transfusions and 
treatments these children also face a great deal of pain coupled with cognitive impairment and 
decreased health-related quality of life. However, there are many therapeutic interventions that can 
affect the quality of children with sickle cell lives in a positive way.
Classification & Pathophysiology
Sickle-cell disease is a “multisystem disease, associated with episodes of acute illness and progressive 
heart damage, it is also one of the most common monogenic disorders worldwide” (Rees, Williams, & 
Gladwin, 2010, p. 2018). Sickle-cell disease derived its name from the sickle-shaped erythrocytes that 
James B. Herrick discovered in 1910. There are three major types of sickle-cell; (1) the most common 
form is homozygosis for the b  allele, (2) hemoglobin SC disease (HbSC) which coinherits the b  and b
alleles and (3) HbS/b-thalassemia which occurs when b  is inherited with a b–thalassemia allele. Our 
bodies produce 20 amino acids and four nucleic bases, which constitute for “standard” genetic code and 
“normal” functioning of body systems. Sickle cell is caused by a mutation in the b-globin gene in which 
the 17  nucleotide is changed from thymine to adenine and the sixth amino acid becomes valine 
instead of glutamine. This mutation causes the affected red blood cells’ nucleus to crystallize, grow and 
fill the erythrocyte, disrupting its structure and flexibility and promoting cellular dehydration, which 
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creates sickled cells. The sickled cells can block blood and other nutrients from travelling through veins 
and arteries causing pain and loss of blood to the brain, organs and extremities.
One of the main problems of sickle-cell disease in children is the development of cerebrovascular 
disease and cognitive impairment. Recurrent episodes of vaso-occlusion (pain) and inflammation result 
in damage to most organs, including the brain, kidneys, lungs, bones, and cardiovascular system, 
which become apparent with increasing age. This is viewed as a serious deficit in children because it not 
only leads to many health related problems, such as irreversible damage to organs as well as ischemic 
(restriction of blood supply and shortage of oxygen and glucose to cellular metabolism) injuries of the 
limbs, bowel, cutaneous tissues and even the heart and brain, which can result in death.
Cognitive Impairment
There are many factors that can contribute to the cognitive impairment of children with sickle cell 
disease. In Abnormalities of the central nervous system in very young children with sickle cell anemia (Wang, 
et al., 1998, p. 140) 39 children between the ages of 7 and 48 months were examined with magnetic 
resonance imaging (MRI) and magnetic resonance angiography (MRA). The results showed that very 
young children with sickle cell anemia have infarction in the brain and/or stenosis of major cerebral 
arteries, similar to those reported in older children and even adults. The study indicated that lesions of 
vascular stenosis and brain ischemia occur in the first few years of life even in neurologically 
asymptomatic patients. Additionally, three patients experienced strokes with lesions, which are 
usually associated with abnormalities in adults with sickle cell disease.
This shows that seizures can be prevalent in the younger population contributing to loss of cognitive 
ability from strokes emphasizing the association of this symptom with significant pathologic conditions 
of the central nervous system, whether related to neonatal hypoxia or ischemia from vaso-occlusion. 
One report from this study addressed the possibility of developmental delay in preschool children with 
sickle cell disease. However, two of the six patients with abnormal imaging study results had Mental 
Developmental Index (MDIs) below 80 (at risk or delayed mental development), suggesting a need to 
look for further correlations among brain imaging, developmental testing, and neurologic history. This 
shows that whether the decrease in development is caused from neonatal hypoxia or ischemia from 
vaso-occlusion, it is still a relevant problem in association with cognitive impairment in children with 
sickle cell disease.
In another study, further evidence of cognitive impairment in children with sickle cell disease can be 
seen in an extensive study of 373 patients with varying classifications of the disease (255 with 
hemoglobin SS and 118 with hemoglobin SC). The participants were given a series of 
neuropsychological tests such as Wechsler Intelligence Scale for Children (WISC-R or WISC-III) and the 
Woodcock-Johnson Math and Reading Achievement Tests, Full-scale IQ (FSIQ) for complete cognitive 
capacity and a MRI. The researchers found that “children and adolescents with SCD between 6 and 18 
years of age have a significant deficit in neuropsychometric performance associated with silent 
infarction and a significant decline in performance with age in certain areas” (Wang, et al., 2001, p. 
395).
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The control group was matched from 4 to 16 years of age. The mean FSIQ scores of the control group 
were between 87.3 and 94.3 with an average of 90. At a mean of about 121⁄2 years of age, the children 
with sickle cell disease had average FSIQ scores of 84.8 (normal MRI findings) and 77.2 (silent infarct 
detected by MRI), which were slightly lower than the scores of the control group. Nine percent of 10-
year-old children with hemoglobin SS (without infarcts detected by MRI) had FSIQ scores <70 (<70 
constitutes for mild retardation). This demonstrates that children with sickle cell disease coupled with 
silent infarcts do present cognitive complications in their complete cognitive capacity specifically in 
verbal comprehension, perceptual reasoning and working memory. This shows the need for effective 
interventions to prevent this cognitive complication.
Furthermore, the study also found the four factors could come into play to explain the neurological 
deficit seen within these children; (1) recurrent micro infarction of the central nervous system; (2) 
chronic hypoxic damage to the brain or diminished pulmonary function; (3) sub-acute brain damage 
that occurred during bouts of hypoxia associated with events such as aplastic crisis, acute chest 
syndrome, and obstructive sleep apnea; and (4) chronic nutritional deficiency associated with 
increased metabolic demands. The effects of recurrent micro infarcts, chronic hypoxemia, and 
repeated tissue ischemia are likely to accumulate, directly resulting in compromised neurocognitive 
function.
Health Related Quality of Life: Functional Disability in Everyday Activities
Pain is a common consequence of sickle cell disease (SCD). Pain in the form of vaso-occlusive episodes 
can begin as early as 6 months of age and can be both frequent and severe. Pain can be associated with 
an increased impairment in daily activities such as school and play as well as potentially impairing 
adjustment in physical, emotional, recreational, educational, and vocational activities in daily 
functioning. In Daily Functioning and Quality of Life in Children With Sickle Cell Disease Pain, “depression 
significantly accounted for variance in both parent and child functional disability assessments. Family 
socioeconomic conditions were significantly independent predictors of health-related quality of life 
(HRQOL) in physical HRQOL, psychosocial HRQOL, and child-reported functional disability.
At the neighborhood/community level economically distressed neighborhoods independently 
contribute to decreased functional outcomes” (Palermo, 2008, p. 838). This shows that family 
socioeconomic factors are significant predictors of functional outcomes demonstrating that family 
income (SES) can cause social stress on the child contributing to lower physical activity and depressive 
nature. At the neighborhood and community level one can see the family SES and neighborhood 
socioeconomic distress was predictive of physical activity and healthy emotional development.
The processes by which neighborhood conditions may influence health outcomes are probably 
multifaceted. For example, the combined effects of SCD pain and low SES on school attendance may 
limit opportunities for recess and physical education, reducing physical HRQOL. Moreover, 
economically distressed neighborhoods are likely to be associated with economically distressed 
schools, which may lack the financial resources to provide playground equipment, physical education, 
and extracurricular activities. Therefore, children with sickle cell disease who live in low economic 
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status neighborhoods may be at increased risk for diminished physical HRQOL due to lack of 
engagement in physical activity.
In Health-related Quality of Life in Children and Adolescents With Sickle Cell Disease, a questionnaire was 
administered to 124 children and adolescents (ages 8 to 18 years with SCD (100 sickle cell anemia, 24 
sickle b-zero thalassemia) and their parents analyzing the scores for children’s and parents’ ratings of 
overall HRQOL and psychosocial health and subscale scores for physical, emotional, social, and school 
functioning were compared with data from healthy children. The study used The PedsQL 4.0 to 
measure opinions or attitudes about problems related to physical, emotional, social, and school 
functioning pertaining to the impact that the child’s illness may have on the family such as school days 
missed by the child or work days missed by the parent, number of days in the hospital, and ER visits.
It was found that both children with SCD and their parents, perceived overall HRQOL and all HRQOL 
subdomains to be lower than scores reported in healthy children. Dale states, “a large proportion of
children with SCD would be ‘at risk’ for impaired overall HRQOL, as well as physical health and school 
functioning.by expressing lower mean scores than those of healthy children” (Dale, et al., 2011, p. 
213). Management of the quality of life for children with SCD of these can be difficult to deal with and 
can create heightened anxiety and reduced confidence. In future research, providing psychosocial 
interventions such as assistance with schoolwork, counseling, or play therapy may contribute to 
increasing the quality of life for children with sickle cell disease.
Therapeutic Interventions
There are many physical complications caused by sickle cell disease. However, acute chest syndrome is 
the most prevalent and perhaps the most uncomfortable for those with SCD. Acute chest syndrome 
(ACS) is an important cause of morbidity and mortality in sickle cell disease (SCD). The Cooperative 
Study of Sickle Cell Disease prospectively followed 3,751 patients enrolled from birth to 66 years of age 
for ACS. There were 1,722 ACS episodes in 939 patients. Young children (age 2 to 4 years) presented 
with fever and cough, and rarely had pain. Acute chest syndrome (ACS) is the second most common 
cause of hospitalization in patients with sickle cell disease (SCD) and is responsible for up to 25% of 
deaths.
The frequency of presenting symptoms was age-dependent with fever and cough being more common 
in young children (age 2 to 4 years) and the incidence of chest pain, shortness of breath, chills, 
productive cough, and hemoptysis increasing with age. This is significant because even though young 
children do not initially experience pain, as they grow older they will experience all the symptoms that 
adults do. Therefore, since there is no cure for sickle cell disease and the complications that come with 
the disease, it is important to intervene to make the quality of life for children with SCD better by not 
having to experience pain associated with acute chest syndrome.
In Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course, Elliott P. Vichinsky states, 
“presenting symptoms during a patient’s first episode of ACS were predictive of symptoms during 
subsequent events. Knowledge of previous symptomatology should allow for earlier diagnosis and 
intervention in subsequent episodes” (Vichinsky, et al., 1997, p.10). This intervention policy could be 
used to help monitor children with SCD as early as two to four years of age to decrease their chances in 
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the future for developing moderate to severe acute chest syndrome. Telfer (2011) states, early 
intervention is important and should include, “Antibiotics (pneumococcal and atypical pneumonia 
cover), careful IV fluid maintenance, to prevent dehydration and avoid over-hydration, effective and 
safe analgesia, bronchodilators and transfusion” (p. 366). If ACS can be seen early and early 
interventions can be made, it is possible that children with SCD and ACS may not experience pain.
Furthermore, a number of independent approaches to therapy have been proposed and developed to 
help reverse the sickling of cells and that could solve the physical pain associated with ACS. Two of 
these approaches have undergone thorough laboratory and clinical investigation: chemical inhibition 
of hemoglobin S polymerization, reduction of the intracellular hemoglobin concentration, and 
pharmacologic induction of hemoglobin F, which can aid in the management of symptoms associated 
with sickle cell disease in children.
Inhibition of Hemoglobin S Polymerization
Franklin Bunn (1997) states, “hemoglobin S polymer is an ideal agent would be readily absorbed 
through the gastrointestinal tract, circulate in the plasma without binding strongly to plasma proteins, 
readily penetrate the erythrocyte membrane, and bind strongly and specifically to hemoglobin S in a 
way that would inhibit polymerization” (pp. 765-766). This would essentially create a chain of blood 
cells that could carry blood through arteries and veins that could aid in vaso-occlusion in regards to 
blood flow and possible regeneration of the classic round erythrocyte. However, a large amount of drug 
would be needed to bind to the approximately 400 g of hemoglobin in patients with SS disease. 
Unfortunately, no antisickling drugs tested thus far have a ratio of efficacy to toxicity that is high 
enough to merit clinical use.
Reduction of the Intracellular Hemoglobin Concentration
It is also discussed in Pathogenesis and Treatment of Sickle Cell Disease, Progress has recently been made 
in the development of drugs that inhibit K+ (potassium) and water loss from SS red cells and thus cause 
a reduction in the intracellular hemoglobin concentration, which results in sickled cells. In a clinical 
trial, “low doses of clotrimazole treatment in five patients with SS disease resulted in a prompt and 
striking reduction in irreversibly sickled cells and an increase in intracellular K+, accompanied by a 
small increase in the hemoglobin concentration” (Bunn, 1997, pp. 765-766). This dose essentially 
increases potassium levels forcing sickled cells to shrink in size and encourage red blood cells to 
revitalize themselves. “Recently, administration of magnesium supplements in transgenic mice with 
sickle cell disease and in 11 patients with SS disease resulted in approximately 50 percent inhibition of 
potassium–chloride cotransport accompanied by a significant decrease in dense erythrocytes and an 
increase in the hemoglobin concentration” (De Franceschi, , Bachir, & Galacteros, 1997, pp. 1849-
1851).
Conclusion
Sickle cell disease is a condition that causes many health related problems such as irreversible damage 
to organs, acute pain and ischemia of the extremities. Through careful research, it is concluded that 
children with sickle cell do suffer from cognitive impairment from; (1) recurrent micro infarction of the 
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central nervous system; (2) chronic hypoxic damage to the brain or diminished pulmonary function; (3) 
sub-acute brain damage that occurred during bouts of hypoxia associated with events such as aplastic 
crisis, acute chest syndrome, and obstructive sleep apnea; and (4) chronic nutritional deficiency 
associated with increased metabolic demands. These recurrent instances direct result in compromised 
neurocognitive function.
The quality of life that children with sickle cell disease is directly affected because of illness from the 
disease. Children that come from low socioeconomic communities and neighborhoods so do have the 
adequate resources to play and engage in physical activity, therefore, they are impacted physically, 
emotionally and socially. Moreover, children with sickle cell disease as well as their parents have self-
reported lower health related quality of life in comparison to healthy children from extensive tests, 
illness, missed days of school/work and lack of physical activity and play.
Finally, therapeutic interventions such as chemical inhibition of hemoglobin S polymerization and 
reduction of the intracellular hemoglobin concentration have made fantastic strives in reversing 
sickled cells caused by the dehydration of regular erythrocytes. Inhibition of hemoglobin S 
polymerization has created a chain of blood cells that could carry blood through arteries and veins that 
could aid in vaso-occlusion in regards to blood flow and possible regeneration of the classic round 
erythrocyte while reduction of the intracellular hemoglobin concentration has focused on created 
potassium infused drugs to force sickled cells to shrink in size and stimulate red blood cells to revitalize 
themselves.
Professional Statement
In the case of sickle-cell disease and its prevalence in children, if I were asked to recommend a course of 
action for sickle-cell anemia in children I would call for interventions and early tests to administered so 
that the prevalence of the disease and its characteristics can been seen early and intervention methods 
can be designed. It is imperative that children born with sickle-cell disease are monitored throughout 
the first couple years of life. A course of action that I could design would include diagnosis of the 
disease at an early age. Second, medications would be administered to decrease the chances of the child 
creating complications such as seizures or hypoxia. There is little evidence that can support that this 
could be done, however, with close monitoring these symptoms could significantly be decreased. 
Third, it would be beneficial to continually educated children with sickle cell, even if they were in the 
hospital or at home. Monitoring neurological defects and consistent education could decrease the 
prevalence of cognitive impairment in children with sickle-cell disease. Fourth, it would be helpful to 
create an environment where children would be able to have physical activity that would not be too 
strenuous so that the children could get enough exercise. This aspect of the program could be 
multifaceted including gradual progress in physical activity to get the children to a “normal” level of 
physical recreation without damage to their bodies.
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